Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quantifying and Treating Myofascial Dysfunction in Post Stroke Shoulder Pain
NCT06718413Phase 2Recruiting
- Sponsor
- Johns Hopkins University
- Start
- Mar 2025
- Primary completion
- Aug 2027
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of recombinant human hyaluronidase PH20 in shoulder pain (2 arms), sponsored by Johns Hopkins University. Primary endpoint: T1ρ relaxation times at 7 weeks. Started Mar 2025; status: recruiting.
02
Drugs
recombinant human hyaluronidase PH20
03
Conditions
shoulder pain
Beyond the preview
Go deeper on NCT06718413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06718413.